Getting a COVID-19 vaccine to 7.8 billion global citizens calls for a combination of meaningful partnerships and innovative supply chain technologyThe Hill: COVID-19 doesn't care about New York or New DelhiMarian W. Wentworth and Wade Warren, January 3, 2021It is both a moral imperative—and in the strategic interest of wealthier countries—to aid in the pursuit of vaccinating 7.8 billion global citizens. Our global health security is only as strong as the weakest link in the chain. Yet even in fully industrialized nations with robust health infrastructure, the logistics of the world’s largest-ever vaccination campaign are daunting. Because of how interconnected the world is today, the economic impacts of COVID-19 have been more severe than in past pandemics. Modern economies depend on global travel, global trade and global supply chains. To combat economic instability and severe global health insecurity, we must look to an ideal combination of meaningful partnerships and innovative supply chain technology to deliver COVID-19 vaccines worldwide.This ideal combination isn’t an entirely new concept. Through decades of work in delivering treatments for malaria and HIV or in making family planning accessible to populations far from industrial centers, we have learned how to hone complex supply chains and work closely with governments, civil society, the private sector and health care workers on locally led solutions. From these experiences, we know more about what a 21st century solution to the supply chain looks like. Take, for example, the idea of the Control Tower, which is a set of tools and techniques that enable experts to proactively manage their end-to-end supply chains through increased visibility and predictive insights. Some experts estimate that as much as 20 percent of vaccines are lost due to cold chain issues or irregularities, but a modern, effective Control Tower can monitor temperature irregularities in real time and guide interventions before the product is lost.
More than $120 million in commitments announced at historic convening for global healthArlington, VA—Last week, Management Sciences for Health (MSH) joined philanthropies, nongovernmental organizations, US government agencies, financial institutions, corporations, universities, Nobel laureate Dr.
Arlington, VA—Management Sciences for Health (MSH), a nonprofit global health organization, has joined forces with the Madagascar Ministry of Public Health (MOPH) to combat an unprecedented measles outbreak with support from the US Agency for International Development (USAID). Since October 2018, the outbreak has infected approximately 140,000 people and claimed the lives of 1,250 Malagasies, including more than 650 children.“MSH is committed to strengthening Madagascar’s health system in partnership with the national government and local communities,” said Marian W.
Arlington, VA—Management Sciences for Health (MSH) joins the global health community in expressing its deep appreciation to the White House for last week’s release of the Global Health Security Strategy, a whole-of-society approach to preventing, detecting, and responding to infectious disease threats.
Ebola health care workers at a home during the October 2014 outbreak. Photo Credit: Fred Hartman/MSH
Arlington, VA—Management Sciences for Health (MSH) stands with the global health community, and with the millions of people we serve across the globe each day, to urge the U.S. government to reconsider planned reductions to programs that are essential to health and national security, and to focus on continuing to invest in strengthening health systems in the world’s poorest countries.
Global health nonprofit joins JEE Alliance advisory board
Arlington, VA—Management Sciences for Health (MSH) is pleased to join the advisory board of the JEE Alliance, a platform for facilitating multisectoral collaboration on health security capacity building and implementation of the International Health Regulations.